Advanced Lung Cancer — CAR-T Cell Immunotherapy for Advanced Lung Cancer
Citation(s)
Safety and Toxicity of CAR-T Cell Immunotherapy in Patients With Advanced Lung Cancer After Standard Treatment Failure: A Single-Arm and Single-Center Phase I Clinical Study